834 related articles for article (PubMed ID: 16511938)
21. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.
Naciute M; Mieliauskaite D; Rugiene R; Maciunaite G; Mauricas M; Murovska M; Girkontaite I
Cytokine; 2017 Aug; 96():41-48. PubMed ID: 28288327
[TBL] [Abstract][Full Text] [Related]
22. Parvovirus B19 infection in Taiwanese patients with hematological disorders.
Lee YM; Tsai WH; You JY; Ing-Tiau Kuo B; Liao PT; Ho CK; Hsu HC
J Med Virol; 2003 Dec; 71(4):605-9. PubMed ID: 14556276
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
25. The relationship between arthritis and human parvovirus B19 infection.
Caliskan R; Masatlioglu S; Aslan M; Altun S; Saribas S; Ergin S; Uckan E; Koksal V; Oz V; Altas K; Fresko I; Kocazeybek B
Rheumatol Int; 2005 Nov; 26(1):7-11. PubMed ID: 15322815
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis for human parvovirus B19-polyarthritis: usefulness of empty particle B19.ELISA and B19-DNA.PCR].
Hatakeyama Y; Ishii K; Murai C; Sugamura K; Mitomo N; Saitoh T; Rikimaru Y; Okazaki T; Sasaki T
Ryumachi; 1998 Oct; 38(5):689-95. PubMed ID: 9852745
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
28. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
29. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
31. Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis.
Aslan B; Serin MS; Aslan G; Kalaci A; Yanat AN; Tezcan S; Emekdas G
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):381-5. PubMed ID: 18096351
[TBL] [Abstract][Full Text] [Related]
32. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
Zakrzewska K; Azzi A; De Biasi E; Radossi P; De Santis R; Davoli PG; Tagariello G
J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251
[TBL] [Abstract][Full Text] [Related]
33. A high prevalence of parvovirus B19 DNA in patients with psoriasis.
Yazici AC; Aslan G; Baz K; Ikizoglu G; Api H; Serin MS; Tezcan S; Emekdas G; Tasdelen B
Arch Dermatol Res; 2006 Oct; 298(5):231-5. PubMed ID: 16862431
[TBL] [Abstract][Full Text] [Related]
34. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
[TBL] [Abstract][Full Text] [Related]
35. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
[TBL] [Abstract][Full Text] [Related]
36. Parvovirus B19 infection in pediatric oncology patients: diagnostic value of clinical and serologic parameters compared with nested PCR.
Soliman Oel-S; Abd El-Aal Hegazi Hasan M; El-Ashry R; Zaghloul MH; Kora B
J Pediatr Hematol Oncol; 2009 Mar; 31(3):173-6. PubMed ID: 19262242
[TBL] [Abstract][Full Text] [Related]
37. Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma.
Li Y; Wang J; Zhu G; Zhang X; Zhai H; Zhang W; Wang W; Huang G
Am J Gastroenterol; 2007 Jul; 102(7):1489-98. PubMed ID: 17459020
[TBL] [Abstract][Full Text] [Related]
38. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
[TBL] [Abstract][Full Text] [Related]
39. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization.
Wang X; Zhang G; Liu F; Han M; Xu D; Zang Y
J Clin Virol; 2004 Sep; 31(1):20-4. PubMed ID: 15288609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]